Cargando…
Identification of 4-aminoquinoline core for the design of new cholinesterase inhibitors
Inhibition of acetylcholinesterase (AChE) using small molecules is still one of the most successful therapeutic strategies in the treatment of Alzheimer’s disease (AD). Previously we reported compound T5369186 with a core of quinolone as a new cholinesterase inhibitor. In the present study, in order...
Autores principales: | Chen, Yao, Bian, Yaoyao, Sun, Yuan, Kang, Chen, Yu, Sheng, Fu, Tingming, Li, Wei, Pei, Yuqiong, Sun, Haopeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941764/ https://www.ncbi.nlm.nih.gov/pubmed/27441112 http://dx.doi.org/10.7717/peerj.2140 |
Ejemplares similares
-
Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease
por: Zhu, Jie, et al.
Publicado: (2018) -
Identification by shape-based virtual screening and evaluation of new tyrosinase inhibitors
por: Li, Qi, et al.
Publicado: (2018) -
Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease
por: Chen, Yao, et al.
Publicado: (2017) -
Identification and validation of immune related core transcription factors GTF2I in NAFLD
por: Zhang, Minbo, et al.
Publicado: (2022) -
Abubidentin A, New Oleanane-type Triterpene Ester from Abutilon bidentatum and its antioxidant, cholinesterase and antimicrobial activities
por: A. Al-Hamoud, Gadah, et al.
Publicado: (2022)